In these cases, the lens capsule, which was originally part of the lens previously removed, will require additional laser surgery
However, CMS announced on April 21 st that they would delay the implementation of the model until at least 2028, perhaps because too few Medicare Part D plans had signed up to participate

Underwriters are also getting better at detecting GLP-1 use through: Prescription databases Medical records requests Follow-up health questionnaires What This Means for Your Clients If currently on GLP-1 medications: Expect questions about medication use and duration Be prepared for potentially higher rates despite current health improvements Consider timing of application if they've been stable on medication for an extended period If recently stopped GLP-1 medications: Underwriters may view recent discontinuation as a risk factor Weight regain could further complicate the application process Medical follow-up showing sustained health improvements may help If planning to start GLP-1 medications: Understand that future applications may be affected by medication use Industry Trends to Watch Some forward-thinking insurance companies are exploring partnerships with GLP-1 providers to improve medication adherence

The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis (Bays et al., NEJM 2025) reported 28.7% mean weight loss at 68 weeks at the 12 mg dose, plus a 75.8% reduction in WOMAC knee pain scores
Because liraglutide produces a less dramatic slowing of gastric emptying compared to the newer weekly medications, sulfur burps tend to be less severe and less frequent, though they still occur
Youve Nicked a Small Blood Vessel Mounjaro is a subcutaneous injection, meaning that it needs to be injected in the fat layer of the skin and not into the blood vessels